Susquehanna International Group
PGEN icon

Susquehanna International Group’s Precigen PGEN Stock Holding History

Susquehanna International Group’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$274K Buy
+70,900
New +$291K ﹤0.01% 11067
2025
Q4 		– Sell
-598,400
Closed -$1.97M – 13286
2025
Q3 		$1.97M Sell
598,400
-276,800
-32% -$782K ﹤0.01% 5833
2025
Q2 		$1.24M Buy
875,200
+862,000
+6,530% +$1.22M ﹤0.01% 6884
2025
Q1 		$19.7K Buy
+13,200
New +$20.8K ﹤0.01% 12114
2024
Q4 		– Sell
-28,300
Closed -$26.9K – 12968
2024
Q3 		$26.9K Sell
28,300
-10,300
-27% -$13K ﹤0.01% 11559
2024
Q2 		$61K Buy
38,600
+17,100
+80% +$24.8K ﹤0.01% 11326
2024
Q1 		$31.2K Buy
+21,500
New +$30.9K ﹤0.01% 11707
2023
Q2 		– Sell
-73,600
Closed -$78K – 12861
2023
Q1 		$78K Buy
73,600
+62,800
+581% +$90.5K ﹤0.01% 11449
2022
Q4 		$16.4K Sell
10,800
-38,600
-78% -$66.4K ﹤0.01% 11827
2022
Q3 		$105K Sell
49,400
-11,200
-18% -$23.6K ﹤0.01% 11662
2022
Q2 		$81K Sell
60,600
-45,000
-43% -$66.8K ﹤0.01% 11650
2022
Q1 		$223K Sell
105,600
-165,400
-61% -$403K ﹤0.01% 10978
2021
Q4 		$1M Sell
271,000
-29,000
-10% -$125K ﹤0.01% 7279
2021
Q3 		$1.5M Buy
300,000
+26,400
+10% +$152K ﹤0.01% 6486
2021
Q2 		$1.78M Buy
273,600
+37,800
+16% +$264K ﹤0.01% 6181
2021
Q1 		$1.63M Buy
235,800
+20,700
+10% +$175K ﹤0.01% 6431
2020
Q4 		$2.19M Buy
215,100
+17,800
+9% +$115K ﹤0.01% 4903
2020
Q3 		$691K Sell
197,300
-49,000
-20% -$233K ﹤0.01% 6984
2020
Q2 		$1.23M Buy
246,300
+67,300
+38% +$229K ﹤0.01% 5446
2020
Q1 		$609K Sell
179,000
-125,900
-41% -$543K ﹤0.01% 6502
2019
Q4 		$1.67M Buy
304,900
+50,300
+20% +$283K ﹤0.01% 4616
2019
Q3 		$1.46M Buy
254,600
+5,000
+2% +$34K ﹤0.01% 4886
2019
Q2 		$1.91M Sell
249,600
-7,000
-3% -$37.7K ﹤0.01% 4260
2019
Q1 		$1.35M Buy
256,600
+44,800
+21% +$311K ﹤0.01% 4422
2018
Q4 		$1.39M Sell
211,800
-255,300
-55% -$2.86M ﹤0.01% 4110
2018
Q3 		$8.04M Sell
467,100
-40,300
-8% -$599K ﹤0.01% 2153
2018
Q2 		$7.07M Sell
507,400
-30,200
-6% -$510K ﹤0.01% 2328
2018
Q1 		$8.24M Buy
537,600
+13,900
+3% +$199K ﹤0.01% 1984
2017
Q4 		$6.03M Buy
523,700
+180,600
+53% +$2.69M ﹤0.01% 2329
2017
Q3 		$6.52M Sell
343,100
-121,900
-26% -$2.51M ﹤0.01% 2193
2017
Q2 		$11.2M Sell
465,000
-21,800
-4% -$478K ﹤0.01% 1604
2017
Q1 		$9.65M Sell
486,800
-5,188
-1% -$116K ﹤0.01% 1668
2016
Q4 		$11.8M Sell
491,988
-538,605
-52% -$15M 0.01% 1406
2016
Q3 		$28.6M Buy
1,030,593
+478,065
+87% +$12.6M 0.01% 790
2016
Q2 		$13.5M Buy
552,528
+161,238
+41% +$4.57M 0.01% 1221
2016
Q1 		$13.1M Sell
391,290
-319,752
-45% -$10.1M 0.01% 1305
2015
Q4 		$21.2M Buy
711,042
+122,896
+21% +$4.14M 0.01% 1095
2015
Q3 		$18.5M Buy
588,146
+38,443
+7% +$1.88M 0.01% 1277
2015
Q2 		$26.6M Buy
549,703
+34,593
+7% +$1.46M 0.01% 1070
2015
Q1 		$22.3M Buy
515,110
+326,979
+174% +$11.7M 0.01% 1156
2014
Q4 		$4.95M Sell
188,131
-3,662
-2% -$80.3K ﹤0.01% 2905
2014
Q3 		$3.41M Sell
191,793
-96,681
-34% -$1.97M ﹤0.01% 3662
2014
Q2 		$6.93M Buy
288,474
+74,708
+35% +$1.51M ﹤0.01% 2587
2014
Q1 		$5.37M Buy
213,766
+107,563
+101% +$2.98M ﹤0.01% 2794
2013
Q4 		$2.42M Sell
106,203
-273,302
-72% -$5.52M ﹤0.01% 3970
2013
Q3 		$8.59M Buy
+379,505
New +$8.76M ﹤0.01% 2055

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Susquehanna International Group's PGEN Position: Q1 2026 in Review

Susquehanna International Group reduced its Precigen (PGEN) stake by 16% in Q1 2026, selling an estimated $334K and leaving 432,711 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #6582.

Susquehanna International Group first reported a position in PGEN in Q3 2013 and has held it in 49 quarters since. The position peaked at $18.2M in Q4 2015. 206 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Susquehanna International Group held 432,711 shares of Precigen worth $1.67M as of Q1 2026.
  • Susquehanna International Group sold 81,469 Precigen shares in Q1 2026, an estimated $334K.
  • Precigen made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6582 holding.
  • Susquehanna International Group first reported a position in Precigen in Q3 2013 and has held it in 49 quarters since.
  • Susquehanna International Group's Precigen position peaked at $18.2M in Q4 2015.
  • 206 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.